Abstract
Our understanding of Na+ homeostasis has recently been reshaped by the notion of skin as a depot for Na+ accumulation in multiple cardiovascular diseases and risk factors. The proposed water-independent nature of tissue Na+ could induce local pathogenic changes, but lacks firm demonstration. Here, we show that tissue Na+ excess upon high Na+ intake is a systemic, rather than skin-specific, phenomenon reflecting architectural changes, i.e. a shift in the extracellular-to-intracellular compartments, due to a reduction of the intracellular or accumulation of water-paralleled Na+ in the extracellular space. We also demonstrate that this accumulation is unlikely to justify the observed development of experimental hypertension if it were water-independent. Finally, we show that this isotonic skin Na+ excess, reflecting subclinical oedema, occurs in hypertensive patients and in association with aging. The implications of our findings, questioning previous assumptions but also reinforcing the importance of tissue Na+ excess, are both mechanistic and clinical.
Similar content being viewed by others
Introduction
In the last decade, the concept of tissue Na+ shifted the traditionally nephrocentric view of Na+ homoeostasis to the interstitium1,2, where the negatively charged glycosaminoglycans and a TonEBP/NFAT5-VEGF-c-mediated expansion of the lymphatic network serve as a depot and draining system for its accumulation, respectively3,4,5. The proposed water-independent nature of this phenomenon6,7,8 marked its novelty9,10 and its potential implications in the pathogenesis of hypertension and cardiovascular disease at large, as independent studies reported a boosted activation of pathogenic immune-inflammatory cells upon culture in supraphysiological concentrations of Na+ 11,12,13,14,15. The translational value of this evidence relies on the presence of hypertonic (HT) microenvironments in tissues. In humans, increased tissue Na+ concentration has been identified in association with aging and hypertension16, diabetes17, chronic kidney disease18 and acute heart failure19 in skin (where the accumulation was initially described as specific in rodent models3,7) and/or skeletal muscle, as well as in sclerodermic20 or infected skin12, by means of 23Na-MRI. Excess Na+ accumulation upon salt loading, with some sex specificities, was also found in healthy subjects by direct skin chemical analysis21. Importantly, both methods measure Na+ in the whole tissue. We have previously suggested that tissue architecture per se can markedly impact on Na+ content and concentration (Fig. 1)22. Such histochemical23,24 considerations are key to conclude on the HT nature of this Na+ excess, which currently lacks demonstration in humans. In fact, even in rodent models, attempts to isolate hyperosmolar interstitial fluid or lymph proved unsuccessful25. Moreover, the dual osmotically active and inactive nature of interstitial Na+, driving TonEBP-mediated signalling while simultaneously eluding parallel and commensurate water accrual, appears equivocal. On these premises, we sought to test the existence, distribution and putative correlates of HT tissue Na+ accumulation by probative and disprobative approaches (i.e., by verifying and by assuming its occurrence, respectively) in preclinical models of and real-life patients with arterial hypertension.
Our study offers a reappraisal of the tissue Na+ theory, disproves its water-independence in both experimental salt-sensitive hypertension and hypertensive subjects and suggests systemic isotonic (IT) Na+ excess as an important player in the pathogenesis of cardiovascular disease, particularly in association with the process of aging.
Results
Tissue Na+ accumulation is systemic and isotonic
Male and female stroke-prone spontaneously hypertensive (SHRSP) and control Wistar–Kyoto (WKY) rats (12 weeks old) were treated with 1% NaCl in drinking water (high salt, HS) or normal tap water (normal salt, NS) for 3 weeks. In males, baseline blood pressure (BP) was higher, irrespective of strain differences, and salt sensitivity of BP was confined to SHRSPs (Supplementary Fig. 1). Skin Na+ content (mmol g−1 of dry weight (DW)) was increased in SHRSP-HS (+20.7%), as expected; however, we observed similar increases in tissue Na+ also in liver (+10.3%), lungs (+14.8%) and skeletal muscle (+23.6%), but not in myocardium (Fig. 2a and Supplementary Data 1). Apart from skeletal muscle, they were consistently paralleled by increases in tissue water (skin: +14.1%; liver: +4.8%; lungs: +9.0%) with similar trends observed for Na+ concentrations (i.e., normalised for water content, [Na+], mmol L−1; Supplementary Data 1). These changes upon HS were not observed in WKY rats. A sub-analysis for males and females showed almost identical patterns (Supplementary Data 1). Different experimental results for tissue Na+ across organs fit well with a prediction model based on the intracellular/extracellular volume proportion (ECV/ICV) typical of each tissue (Supplementary Fig. 2a)22,26. Lower water and Na+ between control (NS) strains in skin and liver reflect differences in fat content that limit the volume of distribution (and total content, accordingly) of both (Supplementary Fig. 3). Importantly, K+ concentration ([K+]) showed opposite trends to [Na+] (Supplementary Data 1). In physiological conditions, the sum of [K+] and [Na+] in both ECV and ICV is similar, although with opposite predominance of Na+ and K+, respectively; a mixture of ECV and ICV in any proportion would still result in a solution of ~140–160 Na+ + K+ mmol L−1. In all tissues, [Na+ + K+] consistently fell within this range, with no differences between strains or NS/HS allocation (Fig. 2a). Overall, rather than any HT phenomenon, this points to a shift in ECV/ICV ratio and, along with the concomitant increase observed for tissue water, to systemic oedema. The difference in the proportional changes of Na+ and water does not reflect different amounts, as previously suggested, but different sensitivities to oedema detection (Supplementary Fig. 2b)22. In fact, water paralleled Na+ content with identical regression slopes across all groups (Supplementary Fig. 4), except for skeletal muscle where the water-independent ECV/ICV shift is likely due to HS-induced sarcopenia27. The lack of oedema in skeletal muscle and myocardium also reflects the lower physical compliance of these tissues28; of note, in similar experiments conducted in NS-fed but aged rats (52 weeks old), myocardial oedema was detectable and accompanied by extracellular matrix remodelling with an increase in glycosaminoglycans (Supplementary Fig. 5).
The currently proposed mechanistic framework indicates that water-independent tissue Na+ excess is responsible for a VEGF-c mediated signalling via TonEBP/NFAT53,4. Although traditionally associated with the response to osmotic stress29, we observed an increase in TonEBP/NFAT5 expression in skin, lungs and (borderline significant) liver in SHRSP-HS, as well as in myocardium of aged SHRSP, despite the lack of hypertonicity (Fig. 2b and Supplementary Fig. 5). As recently demonstrated for VSMCs30, we speculate that biomechanical (rather than osmotic) stress due to oedema accumulation is responsible for the activation of the lymphangiogenic signal cascade.
Extracellular hypertonic Na+ does not induce hypertensive vascular dysfunction
Blockade of lymphangiogenesis induces development of salt-sensitive hypertension3,4. If the resulting excess tissue Na+ were independent of water (i.e., volume), the expectation is that it would impact on the other determinant of hypertension, i.e., peripheral resistance. To test this hypothesis, we investigated the vascular function of peripheral resistance arterioles from our NS/HS rats. HS treatment did not result in hypercontractile responses to U46619 (a thromboxane-receptor agonist) or KCl but reduced the latter upon repeated stimuli and the sensitivity to the vasorelaxant effect of nitric oxide (NO) in SHRSP (Fig. 3 and Supplementary Table 1). Intriguingly, the concept that vascular swelling could determine increased peripheral resistance and vascular stiffness (to both contraction and relaxation) in the pathogenesis of hypertension dates back to the 1950s31; although it is supported by subsequent evidence32,33,34, which extends to related diseases35 and includes preliminary data from our rats (Supplementary Fig. 6), it still lacks firm demonstration. To test whether an HT environment could directly induce similar changes, arterioles from NS rats were also pre-incubated in an IT or HT (+15 mmol L−1 NaCl) solution. Akin to HS in vivo, HT ex vivo incubation did not affect contractile responses; however, it induced an opposite shift toward an earlier NO-induced loss of pre-constriction tone in both WKY and SHRSP (Fig. 3 and Supplementary Table 2).
This is not reminiscent of classic hypertensive vascular phenotypes and appears more consistent with the neuromuscular signs of hypernatremia (e.g., lethargy and muscle weakness). Overall, these data suggest that impaired drainage of tissue Na+ is unlikely to induce hypertension by directly and adversely modulating peripheral vascular function in a water-independent manner.
Skin Na+ accumulation in hypertensive patients
To translate our preclinical findings to humans, we performed a chemical analysis of arm skin punch biopsies of 76 hypertensive subjects (Supplementary Table 3). The two anatomically distinct layers of epidermis/superficial dermis (ESD) and deep dermis (DD) were analysed separately: as our histochemical approach would predict, [Na+] and [K+] were lower and higher in the ESD compared to DD, respectively (Fig. 4a). In virtually no patients, and thereby in none of the prespecified different clinical subgroups, did [Na++K+] exceed the physiological value of 155 mmol L−1 in either layer (Fig. 4b), thus ruling out any HT accumulation. In both ESD and DD, water content was positively and negatively correlated with [Na+] and [K+], respectively (Fig. 4c); in DD, water, Na+ and K+ contents, but not concentrations, were all positively and highly correlated (Fig. 4c), primarily reflecting their volume of distribution which excluded dermal fat. Accordingly, male DD contained more water, Na+ and K+ than female dermis, which is known to be richer in subcutaneous fat (Supplementary Fig. 7); no such differences were seen in the ESD (Supplementary Table 4). Identical histochemical sex differences were observed in gluteal biopsies from young healthy volunteers (Supplementary Table 5); notably, fluid-retentive36 progestinic states were characterised by higher water and Na+ content, but unchanged [Na+ + K+] (Supplementary Fig. 7). In the hypertensive cohort, age was independently associated with an increase in ESD water and [Na+], and a decrease in [K+] in both layers (Fig. 4d and Supplementary Fig. 8); this likely indicates excess fluid accumulation in the context of reduced tissue cellularity, traditionally accepted as a hallmark of skin aging (Fig. 4d). Salt intake predicted epidermal water content, but not Na+ or K+, independently of age, sex and BMI (Supplementary Fig. 8); at variance with aging, the lack of any significant shift in the Na/K ratio in relation to salt intake would suggest a fluid accumulation evenly distributed between ICV and ECV. Office diastolic BP was inversely associated with ESD water content (ρ = −0.250; p = 0.03) and a surrogate of vascular stiffness, pulse pressure (PP), was positively correlated with Na+/K+ ratios (Fig. 4e); in ESD, the ratio was higher in patients with uncontrolled BP, independent of other covariates. No significant interaction with medications was observed. NT-proBNP levels, positively associated with age (ρ = 0.526; p < 0.001), estimated Na+ intake (ρ = 0.260; p = 0.03) and systolic BP (ρ = 0.288; p = 0.01) and negatively with diastolic BP (ρ = −0.277; p = 0.02), mirrored all measures of skin oedema accumulation (Fig. 4e). Finally, the lack of correlations between histochemical skin data and transepidermal water loss (TEWL)37 (Fig. 4e) stood against the predefined hypothesis that local regulatory mechanisms could make skin an exception to the IT nature of systemic tissue Na+ excess/accumulation via a relative deficit of water.
Discussion
Our study has epistemological, mechanistic, diagnostic and therapeutic implications. First, while we cannot unconditionally exclude an HT Na+ accumulation in any tissue milieu or any clinical/experimental condition, our findings prompt reconsideration of excess tissue Na+ epidemic in light of a simpler histochemical deductive approach24. Numquam est ponenda pluralitas sine necessitate38 (plurality is not to be posited without necessity). Over 80 years ago, Simms and Stolman made cadaveric observations consistent with our conclusions39. Second, this concept of tissue Na+ accumulation is not herein disproved but reinforced and reinterpreted, confirming the importance of regulatory mechanisms like TonEBP/NFAT5 signalling and lymphatic network plasticity in systemic fluid homoeostasis. They should indeed be a focus for future research, together with the biophysical/mechanical impact of cellular rarefaction and clinically overt or subclinical oedema, rather than hyperosmotic niches, on organ function. Third, such foreseeable impact could be tracked, by non-invasive tissue Na+ analysis, in many relevant clinical scenarios beyond sole cardiovascular disease. Finally, the effect of novel natriuretic agents in both prevention and treatment of major cardiovascular events40,41 prompts better identification of those patients who will benefit most. Considering the demonstrated potential of these agents in reducing tissue Na+ content3 and the above functional considerations, it is tempting to speculate that this quest should take into account systemic and/or organ-specific tissue Na+ analysis.
Methods
Animals
All protocols were performed in accordance with the United Kingdom Animals Scientific Procedures Act 1986 (Project Licence 70/9021 held by Delyth Graham) and ARRIVE Guidelines and approved by the institutional ethics review committee (University Animal Welfare and Ethics Review Board, University of Glasgow, Glasgow, UK).
We used SHRSP and WKY rats from colonies inbred at the University of Glasgow since 1991; animals were housed under controlled environmental temperatures (21 ± 3 °C) and lighting (12-h light–dark cycles).
In the main set of experiments, male and female SHRSP and WKY were maintained on standard rat diet (rat and mouse No. 1 maintenance diet; Special Diet Services, Grangemouth, United Kingdom) and provided tap water ad libitum until 11 weeks of age. At 12 weeks, rats (littermates) were randomised to 1% NaCl (HS) or normal drinking water (NS) for 3 weeks (n = 8 males/group and n = 10 females/group, except n = 9 female WKY-NS). Systolic BP was measured at 11 weeks of age (baseline) and then monitored weekly by tail-cuff plethysmography, in an operator-blind fashion whenever possible. In another set of experiments, male SHRSP and WKY were maintained on standard diet and normal tap water ad libitum until 20 and 52 weeks of age (WKY 20 weeks n = 10; WKY 52 weeks = 9; SHRSP 20 weeks = 6; SHRSP 52 weeks = 9).
Tissue harvesting and processing
At the end of the 3 weeks of experimental treatment (main experiment) or at the appropriate age (additional experiment) rats were euthanized by exsanguination under general terminal isoflurane anaesthesia. Myocardium (left ventricle), lungs, liver, descending aorta and samples from shaved abdominal skin and skeletal muscle from the thigh, freed of fascia and tendon, were dissected and snap-frozen in liquid nitrogen. The dissection time was kept to a minimum to prevent evaporation of moisture. Any excess blood was removed by gently blotting the tissues on tissue paper; prior to blotting, heart was cut into transverse sections and aorta lumen gently washed by gravity with a phosphate buffer saline-filled syringe. An aliquot from each tissue was cut on the surgical table and stored into tubes pre-filled with RNA-later (Qiagen Group). All tissues were stored at −80 °C until use.
From frozen tissue samples, aliquots representative of full parenchyma were cut and their wet weights (WW) were measured on a four decimal (0.0001 g) electronic scale (samples WW range = 15–60 μg). To prevent evaporation of tissue water, cutting was performed in a cold room for all the main set of experiments and tissues were transported in eppendorf tubes (Sarstedt) in dry ice. Samples were desiccated at 65 °C in a ThermoMixer (Eppendorf), for >40 h, to a stable DW. Water content was estimated as (WW − DW)/DW and expressed as mg water/mgDW, or as water percentage (W% = (WW − DW) × 100/WW). Dried samples were digested at 65 °C in 20–40 μl of 70% HNO3 (Fisher) for 3 h and, after 1:10 v/v dilution in deionised water (MilliQ), for 2 additional hours. Digestion blank controls (i.e., HNO3 and MilliQ only) were prepared and analysed with the digested samples to confirm the lack of Na+/K+ contaminations. Digested samples and blanks were centrifuged for 1 min at 16,000 × g and stored at room temperature; solubilised supernatants were used for Na+ and K+ quantification, while acid-insoluble residues (present in significant amount in skin and liver samples) were used for total fat quantification.
Na+/K+ measurement
Na+ and K+ in the digested samples were quantified by flame photometry (Sherwood scientific, model 410 C). Na+ and K+ calibration standards of 0–5 ppm (mg/l) were prepared from 1000 ppm solutions (Fisher Chemical) using HNO3– and milliQ– carefully washed glassware. Before photometric measurements, digested samples were further diluted to fall within the range of 0–5 ppm. MilliQ was used as the diluent for both standards and samples after Na+/K+ contamination of HNO3 was excluded on blanks. Na+ and K+ concentrations in the digested sample solutions were calculated against the five-points regression line obtained from the calibration standards. At the calibration used, reported CV% for reproducibility is <2% (i.e., <0.005 mmol/l for both Na and K in the measured sample); in our hands CV% was 1.5 intra-sample and 3% inter-sample (from the same original tissue). Concordance correlation coefficient for replicated (technical) measurements was 0.98 (Supplementary Fig. 9a); random duplicate samples from the same stored tissues showed similarly good reproducibility (Supplementary Fig. 9b, c). All samples from the same type of tissue were analysed in a batch on the same day to minimise technical variability; therefore, few samples irreversibly affected by experimental issues (e.g., accidentally dropped sample, contamination, volume shortage) had to be excluded and are reported as blank cells in the Source Data File. During measurements, blank (diluent) and calibration standards were checked after every block of approximately eight samples to control for drift. Na+ and K+ concentrations in the analysed solutions were used to back-calculate their total content in the digested samples and normalised by DW for Na+ and K+ tissue content (mmol/gDW), or by tissue water for Na+ and K+ tissue concentration (mmol/l). During flame photometry analysis, operators were blind to group allocation of samples.
Fat content analysis
After careful removal of the solubilised material used for Na+/K+ quantification, total fat was extracted from the acid-insoluble residue of skin and liver samples in 200 μl of a solvent mixture (chloroform/methanol, 2:1 v/v; protocol adapted from Lowry et al.24 and Folch et al.42); extraction of the total fat prevented replication of this specific experiment. After overnight incubation at room temperature under agitation, solubilised extracts were transferred to pre-weighed glass tube inserts (Agilent Technologies) and solvents evaporated at 55 °C to constant weight through repeated SpeedVac cycles. Total fat content in tissues was normalised by original WW (%WW).
Histology
Sulphated glycosaminoglycans (sGAG) myocardial content was estimated by Alcian Blue staining of available paraffin-embedded transverse mid-ventricular 5 μm sections from the 20- or 52-week-old WKY and SHRSP male rats (n = 4–5/group). After deparaffinization (Histoclear) and progressive rehydration to distilled water, slides were incubated in Alcian Blue solution (1% Alcian Blue 8GX, Sigma, in 3% acetic acid; pH = 2.5) for 20 min, washed in running tap water for 5 min, rinsed in distilled water and counterstained in Nuclear Fast Red solution (Vector), washed again in running tap water for 1 min and mounted following dehydration.
Random, non-consecutive pictures were taken at ×40 from mid-myocardium (n ≥ 25/animal) and subepicardium (n ≥ 12/animal; immediately below the epicardial layer) with an Olympus BX41 microscope and dedicated image capture software. sGAG were quantified as %AlcianBlue+ stained area after standardised thresholding across pictures, by use of an in-house developed macro (Supplementary Note 1) for ImageJ.
TonEBP gene expression analysis
For all tissues, total RNA extraction was performed using Qiazol (Qiagen) and RNAesy mini-column kit (Qiagen) according to manufacturer’s guide. For qRT-PCR, CDNA was prepared using the High capacity CDNA reverse transcription kit (Applied Biosystems) and analysed using Taqman fast advanced master mix with specific Taqman gene expression assay probes for TonEBP (Rn01762487_m1), GAPDH (Rn01462661 g1), beta-actin (Rn00667869 m1). The expression levels were normalised to either GAPDH (myocardium) or beta-actin (other tissues; housekeeping gene was selected upon evidence of Ct consistency across groups) and were compared and presented as delta Ct values (inversely proportional to gene expression level).
Rat vascular function studies
After organ harvesting for tissue chemical/molecular analysis, mesenteries were also dissected from NS/HS WKY and SHRSP rats and small resistance arteries were isolated as previously described43. Briefly, arterial segments were mounted on isometric wire myographs (Danish Myo Technology, Denmark) filled with 5 ml of physiological saline solution (PSS; 119.0 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO4·7H2O, 24.9 mM NaHCO3, 1.2 mM KH2PO4, 2.5 mM CaCl2 and 11.1 mM glucose) and continuously gassed with a mixture of 95% O2 and 5% CO2 while being maintained at a constant temperature of 37 ± 0.5 °C. LabChart (ADinstruments) was used for data recording. Following 30 min of equilibration, baseline tension was normalised as per DMT recommendations and internal diameter was estimated (https://www.dmt.dk/uploads/6/5/6/8/65689239/dmt_normalization_guide.pdf); vessels with an internal diameter ≥ 500 μm were excluded from further analysis. After normalisation, the contractility of arterial segments was assessed by the addition of KCl (62.5 mmol/L), repeated after 10 min of washout. The contractile response of vessels from the four experimental groups to the thromboxane agonist U46619 was tested with concentration-response curves (10−10 to 3 × 10−6 M); endothelium-independent vasorelaxation was assessed by a dose–response to the NO-donor sodium nitroprussiate (SNP; 10−10 to 10−5 M), following pre-constriction with the U46619 dose that produced 75% of the maximal contractile response. Other vessels from NS-treated animals were incubated for 5 h in PSS or in NaCl-supplemented-PSS (+15 mM NaCl, HT) to test the impact of environmental hypertonicity on vascular function with an ex vivo approach. Duration and tonicity of the incubations were based on previously reported tissue changes with HS diet3,4 and effects of HT culture conditions on rat VSMCs hypertrophy44. After the incubation and one additional KCl stimulation, concentration-response curves for U46619 and SNP were conducted as described above. Vessels with no or trivial response to KCL or U46619 pre-constriction were considered non-viable and their curves were excluded from the analysis.
Human hypertensive subjects
The protocol for the cross-sectional S2ALT (Skin Sodium Accumulation and water baLance in hypertension) study was approved by the West of Scotland Research Ethics Committee 3 (ref. 18/WS/0238) and Greater Glasgow and Clyde NHS Research and Development (ref. GN18CA634). The study was conducted in compliance with the Declaration of Helsinki. Adult, non-pregnant patients were recruited from the High BP clinic, Queen Elizabeth University Hospital, Glasgow between March and July 2019. On the day of their scheduled clinic appointment (9.00 a.m. to 4.30 p.m.), non-pregnant patients willing to take part gave written, informed consented and had anthropometric (body height and weight) and routine office BP measures taken as per current guidelines45; PP was calculated as systolic BP − diastolic BP. Relevant comorbidities and ongoing medications were recorded. On the same occasion we administered a short questionnaire to estimate sodium intake, we measured TEWL and we collected a skin biopsy, serum and EDTA-plasma (for p-Na, p-Urea and p-Creatinine and for NT-proBNP, respectively) and a random urine sample (for albuminuria).
Questionnaire
A short, validated questionnaire46 was administered to patients while waiting for their scheduled visit (Supplementary Note 2). Calculation was made as reported46. Briefly, it included 42 food items with six possible consumption frequency responses: never; one to three times per week; four to six times per week; once a day; twice a day; and three plus times a day. Predefined absolute amounts of sodium per serving size per specific item, according to MRC Food Composition Tables47 were multiplied by the consumption frequency factor that each individual reported, and summed up to a total weekly Na+ intake for each subject, later divided by seven to estimate daily intake. For simplicity, the absolute amounts of Na per serving for each food category were divided by 50 mg Na+ units and rounded to the nearest integer46. The frequency factor in the weekly calculation was taken as the value midway between the upper frequency value of one category and the lower of the next (i.e., 0, 2, 5, 7, 14, 21).
Missing questionnaire data were missing completely at random (Little’s MCAR test, p = 0.593). For five subjects, with more than half of the responses missing, calculations of weekly scores were considered unreliable and excluded. Twenty-two additional subjects had ≤10% missing responses (10/22 had only 1 missing item): median substitution was used for imputation and calculation of weekly scores. Results without imputation were overall identical.
Transepidermal water loss
Before blood collection and skin biopsy and following a ≥20-min period of acclimatisation in a temperature-controlled environment (20–21 °C) and ≥5 min of quiet sitting, TEWL37 was assessed from the flexor portion of the forearm. We used a Tewameter® TM300 probe (Courage & Khazaka GmbH, Cologne, Germany), which estimates TEWL through two pairs of temperature and humidity sensors and Fick’s diffusion law. Readings were automatically stopped and recorded by an MPA 580 system and dedicated software when a ≤0.1 standard deviation was reached.
Skin biopsy
Approximately 40 min before the planned biopsy, lidocaine-based topical anaesthetic cream (LMX4) was applied on the outer upper arm, approximately halfway between the elbow and shoulder; at variance with other commercially available preparations, this cream was found to be free of any detectable Na+ or K+ content at flame photometry analysis in a pilot study in 18 healthy volunteers, used for methods development (SKILLS; University of Glasgow, MVLS College Ethics Committee, ref. 200160109). After cleaning the skin with cotton gauze pads and Na+/K+-free 70% alcohol wipes, skin punch biopsies were performed on the anaesthetised site with a disposable instrument (3–4 mm blade diameter; Kai Medical). The sample was immediately put into a pre-cooled Eppendorf tube, frozen in dry ice and subsequently stored at −80 °C until tissue analysis.
Human healthy subjects
A preliminary cross-sectional study on young healthy volunteers (SOWAS: SOdium and WAter Skin Balance—Insights into Local Regulation) was approved by the University of Glasgow, MVLS College Ethics Committee (ref. 200170153) and conducted between July and December 2018. The study was conducted in compliance with the Declaration of Helsinki. After consent was obtained, normotension confirmed and comorbidities ruled-out during a preliminary screening visit, young (19–35 years old) participants recruited among MVLS students attended a morning visit (starting at 8.00–9.30) after fasting from midnight. For female participants, the date of the main visit was arranged in the early follicular phase of their menstrual cycle, just after period termination; in four cases, due to personal logistics or continuous progesterone treatment (skin implants or vaginal coil) the main visit coincided with a luteal or luteal-like phase. During the visit, we measured BP as previously described, we recorded body weight and bioimpedance-calculated body composition (Tanita, BC-418MA) and collected serum and EDTA-plasma samples. Sodium excretion on 24 h urine collection, initiated after the first micturition of the day before and terminated with the first on the morning of the visit, was assessed semi-quantitatively on site by colorimetric strips (Salinity View, Health Mate) and later by urinary Na+ quantitation by ion‑selective electrodes (ISE indirect Na–K–Cl Cobas, Roche Diagnostics GmbH, Mannheim) to exclude excessively high Na+ consumption (i.e., >5 g/die), confirmed for all participants. With an anaesthetic and surgical protocol identical to what described above, with the exception of the biopsy site, we collected two adjacent 4 mm punch skin biopsies from the upper external gluteal quadrant. One of the samples was cut along a sagittal median plane on the bench to symmetrically include both epidermis and dermis in both halves, immediately put into a pre-cooled Eppendorf tube, frozen in dry ice and subsequently stored at −80 °C until tissue analysis.
Human skin samples analysis
Frozen skin samples were macroscopically transversally cut into a superficial layer, including the epidermis and the immediately adjacent superficial dermis (ESD), and DD layer in a cold room (please see Supplementary Fig. 7). Tissue processing was identical to what described for rat tissues, with the exception of a five decimal (0.00001 g) scale (Ohaus, DV214CD) used for weight measurements due to small size of the samples. Water and Na+/K+ contents were measured as described for rat tissues. The few missing values secondary to technical issues or insufficient sample were excluded.
Paraffin-embedded samples from the pilot studies mentioned above were used for histological pictures, representative of sex and age differences. After deparaffinization (Histoclear) and progressive rehydration, 5 μm sections including both epidermis and dermis were stained with Picrosirius Red (1 h) or, after overnight antigen retrieval at 40 °C in Unitrieve (Innovex Biosciences), with standard DAPI staining protocols.
Statistics
All data were collected in Microsoft Excel spreadsheets. Statistical analysis was performed using Prism (GraphPad Software) and SPSS (IBM).
Categorical variables are presented as absolute numbers and percentages and compared by χ2 test. The effect of two factors (e.g., strain and salt load) on different quantitative response variables in the experimental groups was tested by two-way ANOVA. For predefined comparisons (e.g., the effect of HS vs. NS) we used Fisher least-significant-difference test (animals) or Student’s t test (humans) for normally distributed variables (presented as mean ± SD or, graphically, as mean [95% CI]) or Mann–Whitney test for non-normally distributed variables (presented as median [interquartile range] or, graphically, as median [95% CI]). For post hoc comparisons (e.g., between strains or sexes), labelled as such in the relative figures/tables, Holm–Sidak test was used. Data tested against a specified value were analysed by one-sample t-test. Prior to any comparison, outliers were identified by ROUT method (Q = 1%) and excluded from analysis but reported on the relative figures. Regression curves were derived by least-square method and compared by Extra sum-of-squares F test; for vascular function analysis, maximal contraction/relaxation and (Log)EC50/IC50 were independently compared. Correlations were ascertained by Pearson test, upon appropriate transformation of skewed variables to attain normal distribution. Univariable and multivariable (including age, sex, BMI and estimated Na intake) linear regression models were used and results were presented as standardised B coefficients (95% CI). The α level was set at 0.05 and all statistical tests were two tailed (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the findings of this study are available within the paper and its supplementary information. Source data are provided with this paper.
References
Titze, J. & Luft, F. C. Speculations on salt and the genesis of arterial hypertension. Kidney Int. 91, 1324–1335 (2017).
Nijst, P. et al. The pathophysiological role of interstitial sodium in heart failure. J. Am. Coll. Cardiol. 65, 378–388 (2015).
Machnik, A. et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat. Med. 15, 545–552 (2009).
Wiig, H. et al. Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J. Clin. Investig. 123, 2803–2815 (2013).
Karlsen, T. V. et al. High-salt diet causes expansion of the lymphatic network and increased lymph flow in skin and muscle of rats. Arterioscler. Thromb. Vasc. Biol. 38, 2054–2064 (2018).
Titze, J. et al. Reduced osmotically inactive Na storage capacity and hypertension in the Dahl model. Am. J. Physiol. Ren. Physiol. 283, F134–F141 (2002).
Titze, J. et al. Osmotically inactive skin Na+ storage in rats. Am. J. Physiol. Ren. Physiol. 285, F1108–F1117 (2003).
Titze, J. et al. Internal sodium balance in DOCA-salt rats: a body composition study. Am. J. Physiol. Ren. Physiol. 289, F793–F802 (2005).
Elijovich, F. et al. Salt sensitivity of blood pressure: a scientific statement from the American Heart Association. Hypertension 68, e7–e46 (2016).
Mancia, G. et al. The technical report on sodium intake and cardiovascular disease in low- and middle-income countries by the joint working group of the World Heart Federation, the European Society of Hypertension and the European Public Health Association. Eur. Heart J. 38, 712–719 (2017).
Kleinewietfeld, M. et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496, 518–522 (2013).
Jantsch, J. et al. Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense. Cell Metab. 21, 493–501 (2015).
Zhang, W. C. et al. High salt primes a specific activation state of macrophages, M(Na). Cell Res. 25, 893–910 (2015).
Barbaro, N. R. et al. Dendritic cell amiloride-sensitive channels mediate sodium-induced inflammation and hypertension. Cell Rep. 21, 1009–1020 (2017).
Van Beusecum, J. P. et al. High salt activates CD11c(+) antigen-presenting cells via SGK (serum glucocorticoid kinase) 1 to promote renal inflammation and salt-sensitive hypertension. Hypertension 74, 555–563 (2019).
Kopp, C. et al. 23Na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients. Hypertension 61, 635–640 (2013).
Karg, M. V. et al. SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial. Cardiovasc. Diabetol. 17, 5 (2018).
Schneider, M. P. et al. Skin sodium concentration correlates with left ventricular hypertrophy in CKD. J. Am. Soc. Nephrol. 28, 1867–1876 (2017).
Hammon, M. et al. 23Na magnetic resonance imaging of the lower leg of acute heart failure patients during diuretic treatment. PLoS ONE 10, e0141336 (2015).
Kopp, C. et al. Na+ deposition in the fibrotic skin of systemic sclerosis patients detected by 23Na-magnetic resonance imaging. Rheumatology 56, 556–560 (2017).
Selvarajah, V. et al. Novel mechanism for buffering dietary salt in humans: effects of salt loading on skin sodium, vascular endothelial growth factor C, and blood pressure. Hypertension 70, 930–937 (2017).
Rossitto, G., Touyz, R. M., Petrie, M. C. & Delles, C. Much Ado about N…atrium: modelling tissue sodium as a highly sensitive marker of subclinical and localized oedema. Clin. Sci. 132, 2609–2613 (2018).
Lowry, O. H. & Hastings, A. B. Histochemical changes associated with aging: I methods and calculations. J. Biol. Chem. 143, 257–269 (1942).
Lowry, O. H. et al. Histochemical changes associated with aging; liver, brain, and kidney in the rat. J. Gerontol. 1, 345–357 (1946).
Nikpey, E. et al. High-salt diet causes osmotic gradients and hyperosmolality in skin without affecting interstitial fluid and lymph. Hypertension 69, 660–668 (2017).
Bhave, G. & Neilson, E. G. Body fluid dynamics: back to the future. J. Am. Soc. Nephrol. 22, 2166–2181 (2011).
Kitada, K. et al. High salt intake reprioritizes osmolyte and energy metabolism for body fluid conservation. J. Clin. Investig. 127, 1944–1959 (2017).
Wiig, H. & Reed, R. K. Interstitial compliance and transcapillary starling pressures in cat skin and skeletal muscle. Am. J. Physiol. 248, H666–H673 (1985).
Miyakawa, H., Woo, S. K., Dahl, S. C., Handler, J. S. & Kwon, H. M. Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc. Natl Acad. Sci. USA 96, 2538–2542 (1999).
Scherer, C. et al. Arterial wall stress controls NFAT5 activity in vascular smooth muscle cells. J. Am. Heart Assoc. 3, e000626 (2014).
Tobian, L. Jr & Binion, J. T. Tissue cations and water in arterial hypertension. Circulation 5, 754–758 (1952).
Tobian, L., Janecek, J., Tomboulian, A. & Ferreira, D. Sodium and potassium in the walls of arterioles in experimental renal hypertension. J. Clin. Investig. 40, 1922–1925 (1961).
Sullivan, J. M., Prewitt, R. L., Ratts, T. E., Josephs, J. A. & Connor, M. J. Hemodynamic characteristics of sodium-sensitive human subjects. Hypertension 9, 398–406 (1987).
Laffer, C. L., Scott, R. C. 3rd, Titze, J. M., Luft, F. C. & Elijovich, F. Hemodynamics and salt-and-water balance link sodium storage and vascular dysfunction in salt-sensitive subjects. Hypertension 68, 195–203 (2016).
Zelis, R., Delea, C. S., Coleman, H. N. & Mason, D. T. Arterial sodium content in experimental congestive heart failure. Circulation 41, 213–216 (1970).
White, C. P., Hitchcock, C. L., Vigna, Y. M. & Prior, J. C. Fluid retention over the menstrual cycle: 1-year data from the prospective ovulation cohort. Obstet. Gynecol. Int. 2011, 138451 (2011).
Fluhr, J. W., Elsner, P., Berardesca, E. & Mailbach, H. I. Bioengineering of the Skin. Water and the Stratum Corneum 2nd edn (CRC Press, 2005).
Duns, J. Questiones subtilissime Scoti in metaphysicam Aristotelis; Ejusdem de primo rerum principio tractatus; Atque theoremata (ed. Hibernicus, M.) (de Venetiis: per Bonetum Locatellum, 1497).
Simms, H. S. & Stolman, A. Changes in human tissue electrolytes in senescence. Science 86, 269–270 (1937).
Zinman, B. et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373, 2117–2128 (2015).
McMurray, J. J. V. et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N. Engl. J. Med. 381, 1995–2008 (2019).
Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497–509 (1957).
Montezano, A. C., Lopes, R. A., Neves, K. B., Rios, F. & Touyz, R. M. Isolation and culture of vascular smooth muscle cells from small and large vessels. Methods Mol. Biol. 1527, 349–354 (2017).
Gu, J. W. et al. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension 31, 1083–1087 (1998).
Williams, B. et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur. Heart J. 39, 3021–3104 (2018).
Charlton, K. E. et al. Development and validation of a short questionnaire to assess sodium intake. Public Health Nutr. 11, 83–94 (2008).
Langenhoven, M., Kruger, M., Gouws, E. & Faber M. MRC Food Composition Tables 3rd edn (Parow: Medical Research Council, 1991).
Acknowledgements
We gratefully acknowledge the support from Dr. Katriona Brooksbank (University of Glasgow, UoG) for protocol optimisation and ethical/NHS R&D approvals; from Adam Harvey for the rat studies; from Michael Beglan, Holly Yu and Prof. Samuel Jackson’s team (UoG; Chemistry) for the chemical analysis of samples; from Jackie Thomson and Elaine Butler (UoG) for their technical assistance and processing of plasma and urine samples; from Kayley Scott (UoG), Laura Haddow and John McAbney (MyoCORE facility, UoG) for the animal protocols and myography experiments; from all the consultants in the Glasgow High Blood Pressure Clinic (Queen Elizabeth University Hospital) for the recruitment of participants. We are also grateful to Dr. Helen Taylor, EnviroDerm Services (UK distributor of Courage & Khazaka products), for facilitating our access to TEWL equipment and for her technical and scientific support. None of the individuals/companies acknowledged above received compensation for their contributions to this study. This work was supported by the British Heart Foundation (BHF) Centre of Research Excellence Awards, RE/13/5/30177 and RE/18/6/34217 to RMT, C.D. and G.R.; the Academy of Medical Sciences-Newton International fellowship to S.M.; a Carnegie Trust Undergraduate Vacation Scholarship, VAC008890 to J.Y.C. and University of Glasgow Head of College Scholars’ List Scheme Summer Studentship Award 2017/18 to K.S.C. R.M.T. is funded through a BHF Chair award (CH/4/29762). A.C.M. is supported by a Walton Fellowship (University of Glasgow).
Author information
Authors and Affiliations
Contributions
G.R. had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: G.R. and C.D.; experiment conduction and interpretation: G.R., S.M., J.Y.C., P.B., A.C.M., R.M.T. and C.D.; human study design, recruitment of participants samples/data collection: G.R., J.Y.C., K.S.C., R.M.T. and C.D.; performance, analysis and interpretation of myography data: G.R., K.B.N., R.L.A. and R.M.T.; analysis and interpretation of biochemical data: G.R., P.W. and C.D.; drafting of the paper: G.R. and J.Y.C.; critical revision of the paper for important intellectual content: G.R., S.M., J.Y.C., P.W., M.C.P., R.M.T. and C.D.; statistical analysis: G.R.; supervision: R.M.T., M.C.P. and C.D.; funding: G.R., S.M., J.Y.C., K.S.C., R.M.T. and C.D.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Peer review information Nature Communications thanks Toshiro Fujita, Hyug Moo Kwon, Howard Maibach and the other, anonymous, reviewer for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Source data
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rossitto, G., Mary, S., Chen, J.Y. et al. Tissue sodium excess is not hypertonic and reflects extracellular volume expansion. Nat Commun 11, 4222 (2020). https://doi.org/10.1038/s41467-020-17820-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41467-020-17820-2
This article is cited by
-
Effect of low sodium and high potassium diet on lowering blood pressure and cardiovascular events
Clinical Hypertension (2024)
-
Skin regulation of salt and blood pressure and potential clinical implications
Hypertension Research (2023)
-
Role of Female Sex Hormones and Immune Response in Salt-Sensitive Hypertension Development: Evidence from Experimental Models
Current Hypertension Reports (2023)
-
Effects of pediatric chronic kidney disease and its etiology on tissue sodium concentration: a pilot study
Pediatric Nephrology (2023)
-
The impact of excessive salt intake on human health
Nature Reviews Nephrology (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.